|
|
Fungus in Focus II: An Update from ICAAC and IDSA 2007 |
Program Overview
|
Dr. Thomas Patterson and Dr. James Lewis discuss the latest research on diagnostics, antifungal resistance, treatment strategies, and drug safety presented at the 2007 meetings of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Diseases Society of America (IDSA). Insights on the upcoming IDSA guidelines for Candida and Aspergillus infections are also discussed.
|
Target Audience |
This activity has been designed to meet the needs of physicians and all other healthcare professionals who care for and who may be involved in the diagnosis, management, and treatment of invasive fungal infections.
|
Learning Objectives |
At the conclusion of this activity, participants should be better able to:- Identify key treatment strategies included in the upcoming IDSA guidelines for Candida and Aspergillus infections
|
Faculty |
James S. Lewis, PharmD
Infectious Diseases Pharmacy Programs Manager
Clinical Assistant Professor
University Health System, Department of Pharmacy
University of Texas Health Science Center, San Antonio
San Antonio, Texas
Thomas F. Patterson, MD
Professor of Medicine
The University of Texas Health Science Center
San Antonio, Texas
|
Physician Accreditation |
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of CME, Inc. and Vemco MedEd, LLC. The American Academy of CME is accredited by the ACCME to provide continuing medical education for physicians.
The American Academy of CME designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
|
| Release Date: Friday, November 16, 2007 |
| Expiration Date: Saturday, November 15, 2008 |
Estimated Time to Complete Activity: 0.5 hour
|
Disclosure Statement |
According to the disclosure policy of the Academy, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of the Academy to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
|
Disclosures |
James S. Lewis, PharmD serves as a consultant and a member of the Speakers Bureau for Astellas, Pfizer, and Schering-Plough.
Thomas F. Patterson, MD has received research support from Astellas Pharma US Inc., Enzon, Merck & Co, Nektar Therapeutics, Pfizer, and Schering-Plough Corporation; Dr. Patterson was the principal investigator and the funds were paid to his institution. Additionally, he serves as a consultant to Astellas Pharma US Inc., Basilea, Merck & Co, Pfizer, Schering-Plough Corporation, and Stiefel Laboratories and is a member of the Speakers Bureau for Astellas Pharma US Inc., Merck & Co, Pfizer, and Schering-Plough Corporation.
Planning Committee Members: Karen Wetzel, American Academy of CME and Vesna Drenovac, RPh, MS, and Marco Cicero, PhD, Vemco MedEd have disclosed that they have no relevant financial relationships with any commercial interests.
|
Off-label Disclosure Statement |
At the time of release of this CME activity, the following non-FDA approved off-label uses of the following products are discussed in this educational activity: PCR assay for diagnostic purposes; voriconazole for pediatric use at doses of 7 mg/kg; caspofungin for pediatric use; combination therapy for aspergillosis and zygomycosis.
|
Fee |
There is no fee to participate in this educational activity.
|
Method of Participation |
|
To receive credit for your participation in this CME podcast activity, please complete the following steps:
- Review the CME information including the target audience, learning objective, and disclosures.
- Listen to and review the program carefully.
- Complete the CME Post-test, selecting the most appropriate response to each question.
- Complete the CME Evaluation Form and Credit Information.
- Fax the Evaluation Form and Credit Information to (609) 921-6428 or mail to: American Academy of CME, 186 Tamarack Circle, Skillman, NJ 08558. Documentation of credit will be mailed within 6-8 weeks following receipt of your materials.
|
|
Hardware/Software Requirements
|
| All educational activities are accessible via Internet Explorer and Netscape browsers. A high speed
connection is highly recommended. Windows Media Player, sound card, and speakers are required for
audio. You must have Adobe Acrobat Reader version 4 or above installed on your computer to view PDF
files. If you do not have Acrobat Reader, you can download it for free at Adobe.com |
|
|
Jointly sponsored by the American Academy of CME, Inc. and Vemco MedEd, LLC
Supported by an educational grant from Schering-Plough Corporation
|
|
podcasts
